Hubei Hongyuan Pharmaceutical Technology Co., Ltd. principally engages in the research, development, production, and sale of organic chemical raw materials, pharmaceutical intermediates, raw materials, and pharmaceutical preparations. It also produces lithium hexafluorophosphate, one of the main materials of lithium battery electrolytes. Its key products include organic chemical raw materials, pharmaceutical intermediates, raw materials, and pharmaceutical preparations in the ethylene glycol reaction chain as well as pharmaceutical intermediates in the reaction chain of methyl cyanoacetate and guanidine hydrochloride. The company was founded by Guo Ping Yin on January 21, 2002 and is headquartered in Huanggang, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company